1. Pink Sheet
  2. >>Pathways & Standards
  3. >>Review Pathways

US Antibiotic Incentives Extended To Drugs That Prevent Or Diagnose Infections

 
• By Sue Sutter

Law defines QIDP as antibacterials and antifungals intended to 'treat' serious infections, but FDA now interprets provision more broadly to include preventive and diagnostic products, agency says in a new draft guidance clarifying program's requirements and benefits for sponsors

Antibacterial and antifungal drugs intended to prevent or diagnose a serious or life-threatening infection are eligible for designation as a Qualified Infectious Disease Product (QIDP), US FDA says in a new draft guidance document.

However, the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Review Pathways

More from Pathways & Standards